Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > $$$$$$$

<< Previous

Bullboard Posts

Next >>

Comment by Srxman2001on Aug 30, 2024 1:03pm

103 Views

Post# 36203039

RE:RE:RE:RE:$$$$$$$

Dude. Sit down and listen to your hero talk. Stick your chest out and say I'm a proud supporter. You've learned well from him. You have learned how to put down other people, how to be a fear mongerer and you've learned first hand how narcissism works in a cult. Keep feeding the rich guys ego. That's all he's ever had and ever will. Congrats

<< Previous

Bullboard Posts

Next >>

Sony’s Alpha 1 II: A new professional photography standard?